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Response: Risk of prostate, breast and colorectal cancer after skin cancer diagnosis
Isabelle Soerjomataram1,2* and Esther de Vries1,2
1Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
2Research Department, Comprehensive Cancer Centre South, Eindhoven, The Netherlands
Dear Sir,
Recently, Levi et al.1 reported the risks of developing a
prostate, breast or colorectal cancer after an initial skin cancer
diagnosis. The hypothesis was that skin cancer patients would
have higher vitamin D levels through higher sun exposure and
would, therefore, be at reduced risk of these types of cancer.
Contrary to their expectations, overall, a 15–20% higher risk
of breast, prostate and colorectal cancer was observed in the
cohort as compared with the general population.
This is not the first paper to be written about this topic, some
of which are summarized in other articles by de Vries et al.2,3 and
Nugent et al.4 Most other studies obtained similar results to the
findings of Levi et al. This might be because skin cancer patients
do not have higher vitamin D levels or because vitamin D does
not protect against the development of second tumors. However,
any decreased or an increased risk might also be obscured by
some methodological issues, that are illustrated later.
Surveillance bias
As mentioned by Levi et al.,1 higher frequency of prostate-
specific antigen (PSA) utilization or mammography, especially
among cancer survivors, may lift the relative risk estimates of
second cancer. Levi et al. reported 680 prostate cancers among
31,377 skin cancer patients. Although they did not state the
number of male skin cancer patients, nor their number of accu-
mulated person-years at risk, let us assume that they are about
half: 15,000 patients. In the report from the Dutch group, only
317 prostate cancers were observed among the 13,541 male
skin cancer patients.2 It is known that PSA testing is much
more common in Switzerland than in The Netherlands, which
might be a reason for the differences between these 2 regions.
Even if the real incidence of second prostate or breast cancer
was decreased, such surveillance bias could lead standardized
incidence ratio (SIR) estimates of second cancer to be close to
unity or slightly increased. Studies often stratified risk of second
cancer by time since diagnosis to assess for surveillance bias.1–3,5
A reduction of second cancer risk in the early years after diagno-
sis of the skin cancer2,3 may exclude this bias. In addition, a
reduced risk2,5 that disappeared with time can also further support
the Vitamin D hypothesis. After a skin cancer diagnosis, most
patients would reduce their exposure to the sun, causing a gradual
decrease of Vitamin D level6 thus diminishing protective effect
against cancer.
Stratifications
Stratification by sub-group of first skin cancer:
Histology, location, age and gender
Epidemiological studies have suggested different sun expo-
sure pattern to be related with different subgroups and location
of skin cancer, and age as well as gender.7,8 Squamous cell car-
cinomas (SCC), skin cancers in the head and neck region, older
age and male gender are usually associated to chronic sun ex-
posure. Therefore, patients with these characteristics are
expected to have a higher Vitamin D status and possibly a
lower risk of certain second cancers.2–5,9 Indeed, similar to
previous studies,2–4,10 Levi et al. found lower SIR point esti-
mates for SCC and basal cell carcinoma (BCC) than for mela-
noma, although no decreased risks were observed. After strati-
fication by location and subtype of skin cancer, neither Levi et
al.1 nor Milan et al.11 found a relationship, though others found
the contrary.2,3 Finally, though Levi et al. did not stratify by
gender they stratified by age, but no systematic differences
were observed between the young (<60) and elderly (60)
patients.
Stratification by stage
Vitamin D has been shown to inhibit invasiveness, angio-
genesis and metastatic potential, hence delaying cancer pro-
gression and improving prognosis.12,13 For example, analytical
studies showed protective effects of sun exposure against fatal
prostate cancer.2,14 Unfortunately, Levi et al. did not report on
stage at diagnosis, which would not only have shed light on
this aspect, but would also give some insight into the degree to
which PSA screening has artificially contributed to the high
numbers of prostate cancer cases.
Conclusions
The question as to whether or not skin cancer patients are at
decreased risk of developing some types of second cancers
remains unanswered, as is the question whether or not vitamin
D would be responsible for this. It would be useful to deter-
mine vitamin D levels among the different subgroups of skin
cancer patients at several time-points since diagnosis. As for
studies within cancer registries, international collaborations10
may increase number of cases making stratification possible
with sufficient statistical power.
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